Literature DB >> 7724282

Hemolytic uremic syndrome: MR findings of CNS complications.

Y K Jeong1, I O Kim, W S Kim, Y S Hwang, Y Choi, K M Yeon.   

Abstract

MR findings of a patient with hemolytic uremic syndrome involving the CNS are described. Abnormal high signal intensity on T2-weighted images combined with swelling in the lentiform nucleus, posterior limb of internal capsule, external capsule bilaterally, and left extreme capsule was shown on initial MR; a small low signal intensity in the left putamen on T1- and T2-weighted images and generalized atrophy in the area of high signal intensity on previous T2-weighted images was shown on follow-up MR. These findings indicate infarct with focal hemorrhage, which is one of the histopathological features of CNS complication in hemolytic uremic syndrome.

Entities:  

Mesh:

Year:  1994        PMID: 7724282     DOI: 10.1007/bf02012739

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  8 in total

1.  Hemolytic uremic syndrome: MR findings of CNS complications.

Authors:  J W Sherwood; W A Wagle
Journal:  AJNR Am J Neuroradiol       Date:  1991 Jul-Aug       Impact factor: 3.825

2.  Neurological complications of hemolytic-uremic syndrome.

Authors:  J S Hahn; P L Havens; J J Higgins; P P O'Rourke; J A Estroff; R Strand
Journal:  J Child Neurol       Date:  1989-04       Impact factor: 1.987

3.  The hemolytic-uremic syndrome.

Authors:  C A Gianantonio; M Vitacco; F Mendilaharzu; G E Gallo; E T Sojo
Journal:  Nephron       Date:  1973       Impact factor: 2.847

4.  Clinical and pathologic aspects of central nervous system involvement in the haemolytic uraemic syndrome.

Authors:  J C Rooney; R M Anderson; I J Hopkins
Journal:  Proc Aust Assoc Neurol       Date:  1971

5.  Risk factors for the central nervous system manifestations of gastroenteritis-associated hemolytic-uremic syndrome.

Authors:  N Cimolai; B J Morrison; J E Carter
Journal:  Pediatrics       Date:  1992-10       Impact factor: 7.124

6.  Neurological involvement in hemolytic-uremic syndrome.

Authors:  K J Sheth; H M Swick; N Haworth
Journal:  Ann Neurol       Date:  1986-01       Impact factor: 10.422

7.  The importance of nonrenal involvement in hemolytic-uremic syndrome.

Authors:  K Upadhyaya; K Barwick; M Fishaut; M Kashgarian; N J Siegel
Journal:  Pediatrics       Date:  1980-01       Impact factor: 7.124

8.  Lacunar infarction of the basal ganglia as a complication of hemolytic-uremic syndrome. MRI and clinical correlations.

Authors:  F J DiMario; H Brönte-Stewart; J Sherbotie; M E Turner
Journal:  Clin Pediatr (Phila)       Date:  1987-11       Impact factor: 1.168

  8 in total
  12 in total

1.  Hemoconcentration: a major risk factor for neurological involvement in hemolytic uremic syndrome.

Authors:  Gianluigi Ardissino; Valeria Daccò; Sara Testa; Cristina Felice Civitillo; Francesca Tel; Ilaria Possenti; Mirco Belingheri; Pierangela Castorina; Nicolò Bolsa-Ghiringhelli; Silvana Tedeschi; Fabio Paglialonga; Stefania Salardi; Dario Consonni; Elena Zoia; Patrizia Salice; Giovanna Chidini
Journal:  Pediatr Nephrol       Date:  2014-08-23       Impact factor: 3.714

2.  Neurological involvement in a child with atypical hemolytic uremic syndrome.

Authors:  Bérengère Koehl; Olivia Boyer; Nathalie Biebuyck-Gougé; Manoelle Kossorotoff; Véronique Frémeaux-Bacchi; Nathalie Boddaert; Patrick Niaudet
Journal:  Pediatr Nephrol       Date:  2010-08-17       Impact factor: 3.714

3.  CT and MRI in haemolytic uraemic syndrome with central nervous system involvement: distribution of lesions and prognostic value of imaging findings.

Authors:  Marc Steinborn; Steffen Leiz; Klaus Rüdisser; Martin Griebel; Thomas Harder; Helmut Hahn
Journal:  Pediatr Radiol       Date:  2004-07-29

4.  Cerebral magnetic resonance imaging findings in adults with haemolytic uraemic syndrome following an infection with Escherichia coli, subtype O104:H4.

Authors:  U Löbel; B Eckert; O Simova; M Meier-Cillien; S Kluge; C Gerloff; J Röther; T Magnus; J Fiehler
Journal:  Clin Neuroradiol       Date:  2013-06-29       Impact factor: 3.649

5.  Central nervous system involvement in adults with epidemic hemolytic uremic syndrome.

Authors:  M Wengenroth; J Hoeltje; J Repenthin; T N Meyer; F Bonk; H Becker; S Faiss; O Stammel; P P Urban; R Bruening
Journal:  AJNR Am J Neuroradiol       Date:  2013-01-10       Impact factor: 3.825

6.  Distribution of Gb(3) Immunoreactivity in the Mouse Central Nervous System.

Authors:  Fumiko Obata; Tom Obrig
Journal:  Toxins (Basel)       Date:  2010-08       Impact factor: 4.546

7.  Hemolytic uremic syndrome: new developments in pathogenesis and treatment.

Authors:  Olivia Boyer; Patrick Niaudet
Journal:  Int J Nephrol       Date:  2011-08-17

8.  Efficacy of Urtoxazumab (TMA-15 Humanized Monoclonal Antibody Specific for Shiga Toxin 2) Against Post-Diarrheal Neurological Sequelae Caused by Escherichia coli O157:H7 Infection in the Neonatal Gnotobiotic Piglet Model.

Authors:  Rodney A Moxley; David H Francis; Mizuho Tamura; David B Marx; Kristina Santiago-Mateo; Mojun Zhao
Journal:  Toxins (Basel)       Date:  2017-01-26       Impact factor: 4.546

9.  Alternating hemiparesis in the context of hemolytic uremic syndrome and COVID-19 positivity.

Authors:  Hugh D Simpson; Erica Johnson; Jeffrey Britton; Sherri Braksick
Journal:  Epilepsy Behav Rep       Date:  2021-07-05

10.  A translational murine model of sub-lethal intoxication with Shiga toxin 2 reveals novel ultrastructural findings in the brain striatum.

Authors:  Carla Tironi-Farinati; Patricia A Geoghegan; Adriana Cangelosi; Alipio Pinto; C Fabian Loidl; Jorge Goldstein
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.